PF-Atlas › Clinical Trials › NCT04979884
Safety and Effectiveness of Cyclosporin in the Management of COVID19 ARDS Patients in Alexandria University Hospital
cyclosporine · Phase 3
Registry ID
NCT04979884
Phase
Phase 3
Status
Completed
Drug / intervention
cyclosporine
Sponsor
Alexandria University
Start
2022-01-03
About this trial
cyclosporine is evaluated in NCT04979884, a Phase 3 idiopathic pulmonary fibrosis study sponsored by Alexandria University. Current status: Completed.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT04979884 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.